Radiation-Induced Myelosuppression Treatment MarketThe global Radiation-Induced Myelosuppression Treatment Market is ...

Tavlesse (fostamatinib) can now be used by the NHS in England and Wales for patients who have not responded to prior treatment with a thrombopoietin receptor agonist (TPO-RAs), such as Novartis ...

Avatrombopag, known under the brand name DOPTELET, is a thrombopoietin receptor agonist (TPO-RA) that does not compete with thrombopoietin (TPO) for receptor binding. It functions by stimulating ...